Back to search
Malignant Hepatobiliary Neoplasm
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Malignant Hepatobiliary Neoplasm trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Malignant Hepatobiliary Neoplasm trials you may qualify forThis study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing s…
This study evaluates barriers to receiving care and risks associated with developing cancer among patients diagnosed with hepatobiliary cancer.
This clinical trial studies whether Acceptance and Commitment Therapy for patients with hepatobiliary cancers (ACT-HBC) can be used to help improve cancer distr…
The dose escalation phase of this trial identifies the safety, side effects and best dose of ceralasertib (AZD6738) when given in combination with trastuzumab d…
This phase I/II trial studies the best dose and side effects of peposertib and to see how well it works with avelumab and hypofractionated radiation therapy in…